← Leaderboards
Nicholas L Truex
Massachusetts Institute Of Technology
$387,541
Attributed
$596,145
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $265.6K · FY2020–23$500K$375K$250K$125K$0
'20
'21
'22
'23
Funding mix
By agency
NIH$596,145 · 3
By mechanism
P20$417,209 · 2
F32$178,936 · 1
Top collaborators
- Igor B Roninson2 shared
Most similar at Massachusetts Institute Of Technology
Same institution · by research overlap
- Bradley Lether Pentelute$2,969,152
- Graham C Walker$23,287,427
- Angela M. Belcher$1,990,402
- Mary Catherine Andorfer$1,159,313
- Patricia Louise Clark$11,104,727
Others in their field
Other Emerging Leaders on “Therapeutic Protein”
- Susan M Landau · University Of California Berkeley$47,252,026
- Chris Karlovich · Leidos Biomedical Research, Inc.$38,534,220
- Tharick Pascoal · University Of Pittsburgh At Pittsburgh$20,465,582
- Suzanne L Baker · University Of Pittsburgh At Pittsburgh$20,465,582
- Maria C Carrillo · Indiana University Indianapolis$19,445,642
- Gary Fanger · Rise Therapeutics, Llc$19,120,165
Research focus
Therapeutic ProteinMalignant NeoplasmsIn VivoT-Cell ActivationTumor AntigensClinicImmune SystemIn VitroPeptidesProteinsT-LymphocyteTranslationsTissuesCellsDesignEngineeringCancer ImmunotherapyImmunotherapyAntigensBinding ProteinsBindingAnticancer ResearchBaseCell Surface
Grant awards (5)
Synthetic Transcriptional Activators for Cancer Immunotherapy$199,185
P20 · FY2023 · GM · contact PI
Synthetic Transcriptional Activators for Cancer Immunotherapy$218,024
P20 · FY2022 · GM · contact PI
Cytosolic Delivery of Tumor Antigens into Dendritic Cells$47,620
F32 · FY2022 · CA · contact PI
Cytosolic Delivery of Tumor Antigens into Dendritic Cells$66,390
F32 · FY2021 · CA · contact PI
Cytosolic Delivery of Tumor Antigens into Dendritic Cells$64,926
F32 · FY2020 · CA · contact PI